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Summary
Purpose.— In elderly patients, the prognosis of acute coronary syndrome is bleak and the impact
of geriatric factors is as yet unknown. The purpose of this work was to identify factors predictive
of poor outcome at Month 6 in a population of elderly subjects admitted into hospital with acute
coronary syndrome.
Materials and methods.— One hundred and thirty-two patients over 80 years of age were com-
pared with 127 patients under 80, all admitted into a cardiology intensive care unit with
acute coronary syndrome between May 2006 and January 2007, vis-à-vis outcome, mortality
and cardiovascular events, both during the hospital stay and six months later.
Results.— Coronary angiography was performed in fewer of the over-80 group (85.6% versus
97.7%, p < 0.001) but revascularisation rates were comparable in both groups (75.6% versus
78.9%, p = 0.58). During the hospital stay, the incidence of complications was higher (68.8%
versus 38.1%, p < 0.0001) in the older patients as was mortality (18.2% versus 3.2%, p = 0.0001).
At Month 6, all-cause mortality was higher in the octogenarians (28.0% versus 10.6%, p < 0.001).
The independent variables associated with Month 6 all-cause mortality in the over-80 group
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Conclusion.— Les critères gériatriques étudiés ne semblent pas inﬂuencer le pronostic des
sujets âgés hospitalisés pour un syndrome coronarien aigu qui est dominé par le poids des
variables cardiaques.
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ardiovascular disease remains the leading cause of death in
ubjects over 75 years of age [1] and, according to the esti-
ates of the National Institute for Statistics and Economic
tudies (INSEE), one French person in three will be over 60 by
050 (compared with one in ﬁve today) [2]. The proportion
f elderly subjects included in the randomised, controlled
rials is well below their representation in clinical practice
3]. According to studies of patients with acute coronary syn-
rome (ACS), elderly subjects are less well treated, both in
edical and interventional terms [4,5], despite the fact that
ecommended treatment modalities [6,7] are recognised as
eing effective even in those advanced in age [8—15].
In this study, we attempted to pinpoint factors that might
redict poor outcome at six months in subjects over 80 years
f age who had been admitted into a cardiology intensive
are unit with ACS, the purpose being to deﬁne ways of iden-
ifying patients at high risk. In addition to routine cardiologic
riteria, we investigated the predictive power of a series of
eriatric parameters.aterials and methods
rom May 2006 to January 2007, all subjects of 80 years
f age or more admitted into a cardiology intensive care
S
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nit (at Rangueil University Hospital in Toulouse) for ACS
ith elevated troponin and/or modiﬁcation of the ST seg-
ent were included in a single-centre, prospective registry.
he usual clinical and paraclinical parameters were inves-
igated as well as the treatment modalities administered
nd details of discharge treatment. The following geriatric
riteria were also investigated: independence (deﬁned as
ndependence from third parties in daily life), accommoda-
ion (living at home or in an institution), eligibility for the
tate independence allowance, and score on the simpliﬁed
nstrumental Activities of Daily Living Scale (IADL) [16]. The
ata collected were compared with those from a control
opulation composed of all the patients under 80 years of
ge admitted consecutively into a cardiology intensive care
nit with ACS between May and July 2006.
Subjects in both groups were followed up six months later
y telephone, at which time the following details were col-
ected: recurrence of ACS; whether a new revascularisation
rocedure had been performed; stroke; an episode of left
eart failure (deﬁned by the need to instigate diuretics or
tep up their dosage); death (either due to cardiovascular
roblems or some other cause); and treatment details.J. Austruy et al.
were: systolic blood pressure of less than 100mmHg, an admission heart rate of over 100 bpm,
a history of cardiovascular disease, acute coronary syndrome with ST segment elevation in the
anterior territory, and the absence of chest pain.
Conclusion.— In elderly patients admitted into hospital with acute coronary syndrome, geriatric
parameters do not seem to affect prognosis which is dominated by cardiac variables.
© 2008 Elsevier Masson SAS. All rights reserved.
Résumé
Objectif.— Le pronostic des syndromes coronariens aigus du sujet âgé est sombre et l’inﬂuence
des critères gériatriques demeure inconnue. L’objectif de ce travail est d’identiﬁer les facteurs
prédictifs d’évolution défavorable à six mois d’une population de sujets âgés pris en charge
pour un syndrome coronarien aigu.
Matériel et méthode.— Chez 132 patients de plus de 80 ans et 127 patients de moins de 80 ans
admis aux soins intensifs de cardiologie pour un syndrome coronarien aigu entre mai 2006 et
janvier 2007, l’évolution, la mortalité et les évènements cardiovasculaires ont été comparés
en phase hospitalière et au sixième mois.
Résultats.— Les sujets de plus de 80 ans sont moins souvent coronarographiés (85,6 % versus
97,7 %, p < 0,001) mais sont autant revascularisés (75,6 % versus 78,9 %, p = 0,58). L’évolution
intrahospitalière est plus souvent compliquée (68,8 % versus 38,1 %, p < 0,0001) avec une mor-
talité élevée (18,2 % versus 3,2 %, p = 0,0001). Après 80 ans, la mortalité toute cause au sixième
mois est supérieure (28 % versus 10,6 %, p < 0,001). Les variables indépendamment associées à la
mortalité toute cause à six mois chez les plus de 80 ans sont les suivants : une tension artérielle
systolique inférieure à 100mmHg, une fréquence cardiaque supérieure à 100 battements par
minute à l’admission, l’existence d’un antécédent cardiovasculaire, un syndrome coronarien
aigu avec sus-décalage du segment ST dans le territoire antérieur et l’absence de douleur
thoracique.tatistical analysis
n the statistical analysis, all quantitative variables are
resented as the mean± standard deviation. Qualitative
b
u
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RACS in the elderly
variables are expressed as the absolute and relative dis-
tribution. With a view to identifying factors that are
signiﬁcantly associated with the occurrence of a major car-
diovascular event, univariate analysis was carried out. The
Kruskal—Wallis test was used for quantitative variables and,
for qualitative variables, the chi2 test or, if numbers were
insufﬁcient, the Exact Fischer test. Every variable found to
be signiﬁcant in the bivariate analysis was included in a
logistic regression multivariate analysis, in order to identify
factors that are independently and signiﬁcantly associated
with the occurrence of a major cardiovascular event. For
P
O
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Table 1 Population characteristics.
Under 80 n (%
Number 127
Age (years)
Meana 57.8 (13.6)
Medianb 57.5 (47.0; 70
Females 36 (28.1%)
Cardiovascular risk factors
HBP 59 (46.5%)
Abnormal lipid metabolism 61 (48.0%)
Diabetes 29 (23.0%)
Heredity 35 (27.6%)
Smoking (absence) 48 (37.8%)
Active smoking 49 (38.6%)
Cardiovascular history
Ischaemic heart disease 35 (27.6%)
Angioplasty± stenting 20 (15.9%)
Coronary artery bypass 5 (4.0%)
AOLL 10 (7.9%)
Heart failure 8 (6.4%)
Left valve disease 2 (1.6%)
Vascular surgery 1 (0.8%)
Stroke 6 (4.8%)
PM 3 (2.3%)
IC and/or stroke and/or AOLL 40 (31.3%)
Clinical background
Dementia 1 (0.8%)
Depression 4 (3.2%)
COPD 5 (4.0%)
Severe bleeding 1 (0.8%)
Neoplasia 11 (8.7%)
A fall in the preceding 3 months 1 (0.8%)
Lifestyle
Independence Allowance —
Independence —
Institutionalised —
IADL score
0 —
1 —
2 —
3 —
4 —
IADL: instrumental activities of daily living: simpliﬁed version.
a Data expressed in mean (standard deviation).
b Data expressed in median (interquartile intervals 25; 75).451
lood pressure and heart rate, we used the threshold val-
es of the TIMI scale [17]. The signiﬁcance threshold p was
aken as 0.05 for all statistical tests.
esultsopulation
ne hundred and twenty-seven patients under 80 and 132
ver 80 were included. Their characteristics are detailed
) Over 80 n (%) p
132
84.0 (3.1)
.5) 84.0 (81.5; 85.0)
64 (48.8%) <0.001
105(80.1%) <0.0001
45 (34.9%) 0.03
27 (20.9%) 0.69
16 (12.4%) <0.01
87 (68.0%) <0.0001
5 (3.9%) <0.0001
51 (38.9%) 0.05
16 (12.3%) 0.41
8 (6.1%) 0.43
18 (13.9%) 0.13
16 (12.3%) 0.10
9 (6.9%) 0.04
14 (10.8%) <0.001
8 (6.3%) 0.61
8 (6.3%) 0.13
69 (52.3%) <0.001
8 (6.2%) 0.04
7 (5.4%) 0.38
5 (3.9%) 0.99
3 (2.3%) 0.62
13 (10.0%) 0.73
20 (16.3%) <0.0001
24 (22.2%)
57 (49.6%)
12 (10.4%)
10 (9.0%)
14 (12.6%)
14 (12.6%)
37 (33.3%)
36 (32.4%)
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Table 2 Clinical and paraclinical characteristics.
Under 80 n (%) Over 80 n (%) p
Clinical picture (on admission)
Angina pectoris 107 (83.6%) 94 (71.8%) 0.02
Heart rate (beats/min)a 73.6 (17.8) 78.4 (19.4) 0.05
Systolic blood pressure (mmHg)a 128 (21) 132 (27) 0.23
Left or right heart failure 18 (14.2%) 59 (45.7%) <0.0001
Body mass index (kg/m2)a 26.9 (4.8) 25.4 (4.2) 0.03
Electrocardiogram
STACS 59 (49.6%) 53 (45.3%) 0.51
Anterior/STACS 30 (50.8%) 32 (60.4%) 0.31
LBBB 7 (5.6%) 15 (11.5%) 0.09
Q wave 51 (42.9%) 43 (36.8%) 0.34
Fibrillation/atrial ﬂutter 11 (9.1%) 19 (16.1%) 0.10
Grade 2 or 3 AVB 1 (0.08%) 7 (6.03%) 0.01
Test results
Elevated troponin 99 (78.6%) 118 (91.5%) <0.01
Haemoglobin (g/dl)a 14.0 (1.6) 13.0 (1.9) 0.0001
Blood sodium (mmol/l)a 137.8 (3.5) 137.6 (3.5) 0.65
Blood protein (g/l)a 69.9 (6.3) 69.6 (8.3) 0.77
Blood glucose (g/l)b 1.20 (1.00; 1.50) 1.30 (1.10; 1.65) 0.01
Blood creatinine (mol/l)b 90 (82; 106) 107 (88; 133) <0.0001
Creatinine clearance (ml/min)b 85 (66; 104) 40 (32; 50) <0.0001
Chest X-ray
Normal 88 (71.0%) 43 (35.3%) <0.0001
Cardiomegaly 29 (23.4%) 66 (54.1%) <0.0001
Left heart failure 20 (16.3%) 58 (47.5%) <0.0001
Pulmonary shadow 2 (1.6%) 7 (5.8%) 0.1
Pleural effusion 1 (0.8%) 4 (3.3%) 0.21
Ultrasound cardiography
LVEF (%)b 55 (45; 60) 45 (35; 55) <0.0001
Valve disease 1 (0.8%) 18 (14.9%) <0.0001
STACS: acute coronary syndrome with ST segment elevation; LBBB: left bundle branch block.
AVB: atrioventricular block; LVEF: left ventricular ejection fraction.
a Data expressed in mean (standard deviation).
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n Tables 1 and 2. In the over-80 group, the mean age was
4.0± 3.1 compared with 57.8± 13.6 in the under-80 group.
he proportion of women increased with age, with 48.8% in
he older group compared with 28.1% in the younger. Car-
iovascular risk factors and history differed with age: there
ere more people in the over-80 group suffering from hyper-
ension and more were ex-smokers whereas fewer were still
moking or showing abnormal lipid metabolism; their body
ass index was lower, fewer had a family history of coronary
eart disease and more had a history of ischaemic heart dis-
ase, left valve disease or cardiovascular disease (ischaemic
eart disease and/or obliterating arteriopathy of the lower
imbs and/or stroke). Fewer of those under 80 suffered from
ementia and fewer had experienced a fall in the preced-
ng three months. The older patients experienced less chest
ain and more of them presented clinical and/or radiological
vidence of left heart failure. On admission, their systolic
lood pressure and left ventricular ejection fraction (LVEF)
ended to be lower, and their heart rate higher. The propor-
A
t
o
Aion of ST elevation ACS was comparable in the two groups:
9.6% in the under-80 group compared with 45.3% in the
ver-80 group (p = 0.51).
readmission treatment
smaller proportion of the over-80 population was on
ntiplatelet drugs or heparin but more were on diuretics.
nly 17% of the sub-population with STACS were taking
ﬁbrinolytic compared with 44.1% of the corresponding
ounger sub-population: therefore, the time-to instigation
as slightly longer (although not signiﬁcantly so) (Table 3).
ospital treatmentlthough coronary angiography was practised less often in
he over-80 group, it was nevertheless carried out in 85.6%
f them, but more commonly at a later stage (Table 4).
ngiographic ﬁndings differ greatly between the two popula-
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Table 3 Preadmission treatment.
Under 80 n (%) Over 80 n (%) p*
Preadmission treatment
Antiplatelet drugs (aspi/plavix) 101 (88.6%) 87 (65.9%) <0.0001
Heparin 99 (86.8%) 96 (72.7%) <0.01
Diuretics 10 (8.8%) 39 (29.6%) <0.0001
Fibrinolysis 32 (25.0%) 9 (6.8%) <0.0001
Time-to ﬁbrinolysis (min)* 95 (60; 180) 120 (90; 135) 0.41
Anti-GPIIbIIIa (before or during hospitalisation) 8 (6.3%) 17 (12.9%) 0.08
Percentage of ﬁbrinolysis among those with STACS 26 (44.1%) 9 (17.0%) <0.01
* terva
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vData expressed in absolute number (%), median (interquartile in
tions (p < 0.0001): in the over-80 group, the coronary heart
disease was more severe, the proportion with triple arte-
rial involvement was higher (43.4% versus 14.4%, p < 0.0001),
and stenosis was more often detected in the left main artery
(11.5% versus 3.2%, p = 0.01).
There was no difference between the two groups in terms
of the medical strategy adopted or the frequency of a revas-
cularisation procedure, be it transcutaneous angioplasty or
coronary artery bypass surgery. Nevertheless, the median
number of stents implanted was greater in the over-80 group
whereas the proportion of active stents was lower (Table 5).
Outcome in hospital
Fewer of the over-80 group (31.2% versus 61.9%, p < 0.0001)
did not experience any complications at all: most common
were an episode of left heart failure, recurrent ischaemia,
an episode of atrial ﬁbrillation, conduction problems, bleed-
ing, infection, and acute kidney failure (deﬁned by a 25%
increase in blood creatinine). Octogenarian mortality was
18.2% compared with 3.2% in the younger group (p = 0.0001)
(Table 6).
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Table 4 Coronary angiography.
Coronary angiography
Not carried out
Postponeda
Postponed/STACSa
Postponed/NSTACSa
Number of narrowed (> 50%) and obstructed vesselsb
No stenosis > 50%
1 (one artery)
2 (two arteries)
3 (three arteries)
Stenosis of the LM> 50%
Percentage of triple-artery involvement vs. none, single or do
Data expressed in absolute number (%).
a Time since admission /= 0.
b Comparison of the distribution between the 4 categories (no artery >
Stenosis of the LM (left main artery) is considered as equivalent to douls 25; 75).
At discharge, recommended postinfarction drugs were
rescribed to a higher proportion of the over-80 group. How-
ver, while the prescription of antiplatelet drugs and statins
as comparable in both groups, beta-blockers, angiotensin-
onverting enzyme (ACE) inhibitors and/or angiotensin
eceptor II (ARA II) inhibitors were prescribed to fewer of
he octogenarians (Table 7).
onth 6 follow-up
o subjects were lost to follow-up in the over-80 group, and
nly four in the under-80 group. More of those over 80 had
ied since discharge but only the difference in cumulative
eath rate was statistically signiﬁcant (28.0% versus 10.8%,
< 0.001). The only postdischarge event that was signiﬁ-
antly higher in the over-80 group was heart failure (37.7%
ersus 12.4%, p < 0.0001) Table 8.The octogenarians were still being correctly treated at
onth 6 (Table 7) with 90.5% on antiplatelet drugs, but
here was still a lower proportion on beta-blockers and ACE
nd/or ARA II inhibitors, although the difference vis-à-vis
he younger population had diminished (Fig. 1).
Under 80 n (%) Over 80 n (%) p
3 (2.3) 19 (14.4) <0.001
55 (47.0) 83 (73.5) <0.0001
8 (13.8) 16 (36.4) <0.01
40 (78.4) 54 (96.4) <0.01
< 0.0001
13 (10.4) 6 (5.31) —
58 (46.4) 33 (29.2) —
35 (28.0) 24 (21.2) —
18 (14.4) 49 (43.4) —
4/125 (3.2) 13/113 (11.5) 0.01
uble 18 (14.4) 49 (43.4) < 0.0001
50%, single, double, triple).
ble arterial involvement.
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Table 5 Therapeutic strategy.
Under 80 n (%) Over 80 n (%) p
Therapeutic strategya 0.58
Medical 27 (21.1%) 31 (24.4%) —
Angioplasty 98 (76.6%) 91 (71.7%) —
CBS 3 (2.3%) 5 (3.9%) —
Number of stents implanted per patient (among dilated patients)b 1 (1; 2) 2 (1; 2) 0.03
Active stents (among dilated patients) 37 (37.8%) 8 (8.8%) <0.0001
the th
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aa Global test: the therapeutic strategy is not different whatever
b Data expressed in absolute number (%) or median (interquartile
actors predicting poor outcome at Month 6
nivariate analysis identiﬁed the factors associated with
verall death risk as a history of heart failure, cardio-
ascular or valve disease, atrioventricular block, signs of
eart failure and the absence of chest pain on admis-
ion, and the nonadministration of statins and ACE or ARA II
nhibitors. The patients who died had shown, on admis-
ion, lower blood pressure and LVEF, and higher heart
ate. Fewer had undergone revascularisation and those
ith kidney failure had higher blood creatinine readings
Tables 9 and 10).
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Table 6 Outcome in hospital.
Under 8
Troponin peak (ng/ml)a 38.5 (4
No complicationsb 78 (61.
Heart failure 13 (10.
Killip 1 113 (89
Killip 2 1 (0.8%
Killip 3 6 (4.8%
Killip 4 6 (4.8%
Recurrent ischaemia 0 (0%)
Episode of ﬁbrillation/atrial ﬂutter 2 (1.6%
Tachycardia or ventricular ﬁbrillation 10 (7.9
Conduction problem 2 (1.6%
Implantation of a pace maker 0 (0%)
Mechanical complication 5 (3.9%
Stroke 1 (0.8%
Bleeding 4 (3.1%
Bleeding necessitating transfusion 4 (3.1%
Infection 11 (8.7
Lung 3
Urinary tract 4
Acute kidney failure 33 (26.
Dialysis (in those with KF) 3 (9.1%
Confusion/agitation 3 (2.4%
Death 4 (3.2%
Cardiac death (among the deaths) 4 (100%
Haemoglobin at discharge (g/dl)* 13.4 (1
Creatinine clearance at discharge (ml/min)a 81.7 (6
* Data expressed in absolute number (%) or mean (standard deviation)
a Data expressed in median (interquartile intervals 25; 75).
b None of the following complications: recurrence, AF/ﬂutter, ventri
complication, stroke, bleeding, infection, acute kidney failure, death.erapeutic decision.
rvals 25; 75).
According to the multivariate analysis, the admission
ariables which signiﬁcantly and independently correlated
ith cumulative Month 6 mortality were the existence of a
istory of cardiovascular disease, the absence of chest pain,
rior STACS, a systolic blood pressure of 100mmHg or below,
nd a heart rate of 100 bpm or over (Table 11).iscussion
he characteristics of this octogenarian population are com-
arable to those reported in the large-scale studies apart
0 n (%) Over 80 n (%) p*
.5; 101.0) 24.0 (7.0; 100.0) 0.89
9%) 41 (31.2%) <0.0001
3%) 72 (55.0%) <0.0001
.7%) 59 (45.0%) <0.0001
) 35 (26.7%) <0.0001
) 23 (17.6%) <0.001
) 14 (10.7%) 0.01
11 (8.5%) <0.001
) 41 (31.5%) <0.0001
%) 9 (6.9%) 0.76
) 15 (11.5%) <0.01
6 (4.6%) 0.03
) 8 (6.2%) 0.42
) 4 (3.1%) 0.37
) 15 (11.5%) 0.01
) 11 (8.5%) 0.07
%) 44 (33.8%) <0.0001
26
15
4%) 55 (42.3%) 0.01
) 6 (11.1%) 0.99
) 20 (15.4%) 0.001
) 24 (18.2%) 0.0001
) 21 (87.5%) 0.99
.8) 12.3 (1.8) <0.0001
0.7; 101.1) 39.3 (29.4; 47.3) <0.0001
.
cular arrhythmia, conduction problem, pace maker, mechanical
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Table 7 Treatment at discharge and at Month 6.
Discharge treatment Treatment at Month 6
Under 80 n (%) Over 80 n (%) p* Under 80 n (%) Over 80 n (%) p*
Number of drugs* 6 (5; 6) 6 (5; 7) 0.02 7 (6; 9) 7 (6; 9) 0.64
Aspirin 101 (87.8%) 80 (84.2%) 0.45 118 (95.2%) 100 (92.6%) 0.41
Clopidogrel 80 (69.6%) 53 (55.8%) 0.04 104 (83.9%) 83 (76.8%) 0.18
Asprin and/or clopidogrel 103 (89.6%) 86 (90.5%) 0.82 119 (96.0%) 102 (94.4%) 0.59
Oral anticoagulants 4 (3.5%) 11 (11.6%) 0.02 3 (2.4%) 8 (7.4%) 0.07
Beta-blocker 84 (73.0%) 58 (61.0%) 0.06 105 (84.7%) 72 (66.7%) <0.01
ACE and/or ARA II inhibitor 83 (72.2%) 58 (61.0%) 0.09 97 (78.2%) 58 (53.7%) <0.0001
Diuretic 24 (20.9%) 45 (47.4%) <0.0001 14 (11.3%) 43 (39.8%) <0.0001
Antialdosterone 3 (2.6%) 1 (1.0%) 0.63 2 (1.6%) 0 0.50
Statin 97 (84.3%) 68 (71.6%) 0.02 103 (83.1%) 84 (77.8%) 0.31
Fibrate 1 (0.9%) 0 0.99 1 (0.8%) 0 0.99
Nitrated derivative 2 (1.7%) 17 (17.9%) <0.0001 7 (5.6%) 14 (13.0%) 0.05
Potassium stimulant 5 (4.3%) 9 (9.5%) 0.14 9 (7.3%) 13 (12.0%) 0.22
Calcium channel blocker 16 (13.9%) 19 (20.0%) 0.24 13 (10.5%) 24 (22.2%) 0.01
Amiodarone 4 (3.5%) 16 (16.8%) <0.01 10 (8.1%) 20 (18.5%) 0.02
Oral antidiabetic drugs 3 (2.6%) 1 (1.0%) 0.63 2 (1.6%) 2 (1.8%) 0.99
Insulin 6 (5.2%) 12 (12.6%) 0.06 20 (16.1%) 20 (18.5%) 0.63
Proton pump inhibitors 55 (47.8%) 68 (71.6%) <0.001 103 (83.1%) 98 (90.7%) 0.09
Dementia drugs 0 2 (2.1%) 0.20 1 (0.8%) 3 (2.8%) 0.34
Antidepressant 3 (2.6%) 7 (7.4%) 0.19 5 (4.0%) 5 (4.6%) 0.99
Neuroleptic 0 1 (1.0%) 0.45 5 (4.0%) 1 (0.9%) 0.22
Benzodiazepine and/or
hypnotic drug
5 (4.3%) 13 (13.7%) 0.02 0 16 (14.8%) <0.0001
inter
d
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o* Data expressed in absolute number (%) or median (interquartile
from the proportion with STACS, which is higher (45.3% com-
pared with the 30—35% more commonly found in 75- to
84-year-olds [4,5,18,19]. Despite intensive care—–as illus-
trated by the high proportion of coronary angiography
examinations performed and the absence of any difference
between the older and younger patients in the number of
revascularisation procedures performed—–prognosis at six
months remained poor in the over-80 group. The observed
mortality rate of 18.2% is higher than that reported in the
Euro Heart Survey [4] (8% in 75- to 84-year-olds, 16.8% in
those aged 85 and over) and the Grace [5] studies (9.3%
in 75- to 84-year-olds, 18.4% in those aged 85 and over).
Although treatment was correct across the board, it was
more aggressive in the younger patients, an observation
which is consistent with published data [20,21].
c
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Table 8 Month 6 follow-up.
Under 80 n
Death within 6 months of discharge 9 (7.4%)
Main end point: cumulative deaths 13 (10.6%)
Recurrent ACS 16 (13.2%)
New revascularisation 7 (5.8%)
Stroke 1 (0.8%)
Heart failure 15 (12.4%)
* Data expressed in absolute number (%).vals 25; 75).
The Month 6 prognosis in this population is essentially
ependent on admission cardiac parameters, none of which
re speciﬁc to old age.
In octogenarians, hypotension and tachycardia are asso-
iated with increased mortality as has already been shown
y Morrow et al., independently of age, in compilation of
he TIMI risk [17]. As in the GRACE [22] study, STACS in the
nterior territory is associated with a poorer prognosis. The
ssociation between the absence of chest pain and higher
ortality has already been observed, and this independently
f age [23]; this is probably due to delayed diagnosis and, in
onsequence, less effective management (both medical and
nterventional) [8,23,24].
It is surprising that no geriatric prognostic factors
merged in this extremely elderly population. Cardiac
(%) Over 80 n (%) p*
13 (12.0%) 0.24
37 (28.0%) <0.001
19 (17.9%) 0.33
8 (7.6%) 0.58
3 (2.8%) 0.34
40 (37.7%) <0.0001
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at our unit where the high percentage of STACS leads to aigure 1. Treatment at discharge and Month 6 in two groups of
ospital with acute coronary syndrome.
actors are of major importance in this population which
as at higher risk than octogenarian ACS populations studied
itherto [4,5]. Moreover, among our geriatric criteria, we
mitted the phenotypic concept ‘‘frailty’’ [25] as deﬁned
n certain speciﬁc clinical instruments [26,27]. Purser et
l. [28] studied the prevalence of this phenotype in 309
atients over 70 years of age admitted into a cardiology
nit with disease involving at least two main coronary
rteries (coronary angiography having been performed
n all). The phenotype, which was found in 27—63% of
ubjects, depending on the instrument used, seems to be
ndependently associated with excess Month 6 mortality;
oreover, slowwalking (slower than 0.65metres per second)
p
g
b
f
Table 9 Univariate analysis of factors predicting Month 6 mo
N
p
Male/female
History of heart failure: no/yes 1
Cardiovascular history: no/yes
History of left valve disease: no/yes 1
IADL: 0—1/≥ 2
Angina pectoris: no/yes
Grade 2 or 3 AVB: no/yes 1
Fibrillation or atrial ﬂutter: no/yes
Heart failure: no/yes
ACS: NSTACS/STACS
0, single or double arterial/triple arterial involvement
No revascularisation: no/yes
Oral anticoagulants on discharge: no/yes 1
Statins on discharge: no/yes
Beta-blockers on discharge: no/yes
ACE and/or ARA II inhibitors on discharge: no/yes
Diuretics on discharge: no/yes
Benzodiazepine on discharge: no/yes
Data expressed in absolute number (%).
IADL: instrumental activities of daily living: simpliﬁed version.nts—–under and over 80 years of age respectively—–admitted into
nd weakness (a traction force of less than 25 kg) were
he strongest independent predictors of Month 6 mortality.
hus, in this population—–which was bigger and at lower
isk than ours—–geriatric factors emerged as correlating
ith prognosis in elderly patients with coronary heart
isease.
The main limitations of our sample are its single-centre
asis and its limited size. There is also a recruitment biasopulation at higher-than-average risk. It is possible that
eriatric factors contributed to these patients’ prognosis
ut, if so, their impact was masked by the dominant cardiac
actors in this relatively small sample.
rtality.
umber of
atients
Cumulative mortality
at Month 6
p
67/64 18 (26.9%)/19 (29.7%) 0.72
14/16 26 (22.8%)/9 (56.2%) 0.01
63/69 12 (19.0%)/25 (36.2%) 0.03
21/9 28 (23.1%)/7 (77.8%) <0.01
24/87 7 (29.2%)/10 (11.5%) 0.05
37/94 20 (54%)/16 (17.0%) <0.0001
11/7 29 (26.1%)/5 (71.4%) 0.02
99/19 25 (25.2%)/9 (47.4%) 0.05
65/64 11 (16.9%)/24 (37.5%) <0.01
64/53 14 (21.9%)/19 (35.8%) 0.07
64/49 10 (15.6%)/15 (30.6%) 0.06
96/31 18 (18.7%)/14 (45.2%) <0.01
00/8 10 (10.0%)/3 (37.5%) 0.05
24/84 8 (33.3%)/5 (5.9%) <0.01
36/72 7 (19.4%)/6 (8.3%) 0.12
50/58 10 (20%)/3 (5.2%) 0.02
65/43 5 (7.7%)/8 (18.6%) 0.09
92/16 8 (8.7%)/5 (31.2%) 0.02
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Table 10 Univariate analysis of factors predicting Month 6 mortality.
Mean (standard deviation)/ Median
(interquartile interval)b
p
Agea: alive/died 83.9 (3.1)/84 (3.0) 0.92
Weight (kg)a: alive/died 68.9 (13.6)/62.8 (14.3) 0.10
SBP on admission (mmHg)a: alive/died 137.0 (23.6)/116.7 (30.7) <0.0001
HR on admission (cpm)a: alive/died 75.7 (16.6)/86.0 (24.3) <0.01
LVEF (%)b: alive/died 45 (40; 60)/35 (30; 40) <0.0001
Blood glucose (g/l)b: alive/died 1.3 (1.1; 1.6)/1.4 (1.2; 1.7) 0.08
Clearance on admission (ml/min)b: alive/died 42 (33; 51)/35 (25; 42) 0.11
Creatinine peak (mol/l)b: alive/died 172 (140; 218)/200 (180; 243) 0.03
Clearance on discharge (ml/min)b: alive/died 39 (28; 47)/36 (32; 63) 0.79
a Data expressed in mean (standard deviation).
b Data expressed in median (interquartile intervals 25; 75).
Table 11 Multivariate analysis of admission factors which are independently predictive of Month 6 mortality.
OR IC 95% p
CV history (yes vs. no) 5.83 1.79—19.0 <0.01
Atypical symptoms vs. angina pectoris 6.73 2.00—22.6 <0.01
SBP≤ 100 vs. >100 (mmHg) 5.62 1.5—21.1 0.01
HR≥ 100 vs. < 100 (bpm) 3.30 0.99—11.0 0.05
Anterior STACS vs. other forms of ACS 5.10 1.48—17.6 <0.01
vasc
[OR: odds ratio, 95% CI: 95% conﬁdence interval; CV history: cardio
Conclusion
Among octogenarians admitted into a cardiology unit with
ACS, prognosis remained bleak despite intensive medical
and interventional care. Month 6 outcome correlated with
signs of haemodynamic failure on admission, a history of
cardiovascular disease, anterior STACS, and the absence of
chest pain, but not with any of the geriatric factors investi-
gated.
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